Justin Watts, MD, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL, discusses the role of corticosteroids in managing differentiation syndrome (DS) in acute myeloid leukemia (AML), highlighting their effectiveness in ameliorating cytokine release syndrome (CRS), capillary leak syndrome (CLS), and organ damage. Dr Watts emphasizes the importance of using steroids early and at a sufficient dose, as well as the need for better cytoreduction strategies, particularly for monocytic AML, and the potential for developing better models to study DS. This presentation took place at the 8th International Workshop on Acute Leukemias (iwAL) in Cambridge, MA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.